Skip to main content

Remote Job Finders (RJF)

GSK pledges $800M to add biologics production capabilities in Pennsylvania

Starting next year, GSK plans to demolish existing buildings and construct new facilities to support clinical and commercial supply. The investment will create more than 300 new jobs over the next five years, Pennsylvania state officials said.

TRexBio, Retension raise $161.7M in IPOs; City, Iambic set proposed offering terms

TRexBio and Retension Pharmaceuticals are set to debut Friday, bringing this year’s biotech IPO count to 29 as the sector’s rebound continues. City Therapeutics and Iambic Therapeutics hope to push that number even higher.
Scroll to top